The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Opportunities for Tapping into Three-Dimensional Chemical Space through a Quaternary Carbon
Open accessAbstract
A quaternary carbon bears four other carbon substituents or combination of four non-hydrogen substituents at four vertices of a tetrahedron. The spirocyclic quaternary carbon positioned at the center of a bioactive molecule offers conformational rigidity, which in turn reduces the penalty for conformational entropy. The quaternary carbon is a predominant feature of natural product structures and has been associated with more effective and selective binding to target proteins compared to planar compounds with a high sp 2 count. The presence of a quaternary carbon stereocenter allows the exploration of novel chemical space to obtain new molecules with enhanced three-dimensionality. These characteristics, coupled to an increasing awareness to develop sp 3 -rich molecules, boosted utility of quaternary carbon stereocenters in bioactive compounds. It is hoped that this Perspective will inspire the chemist to utilize quaternary carbon stereocenters to enhance potency, selectivity, and other drug-like properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Lovering, F., Bikker, J., & Humblet, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901241e · Cited by 4,495
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Meanwell, N. A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01788 · Cited by 2,655
Brown, D. G., & Boström, J. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01409 · Cited by 1,964
A Planning Strategy for Diversity‐Oriented Synthesis
Burke, M. D., & Schreiber, S. L. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200300626 · Cited by 1,493
Escape from Flatland 2: complexity and promiscuity
Lovering, F. (2013) · MedChemComm · doi:10.1039/c2md20347b · Cited by 1,444
Adenosine Receptors as Therapeutic Targets
Jacobson, K. A., & Gao, Z.-G. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1983 · Cited by 1,431
Targeting RAS–ERK signalling in cancer: promises and challenges
Samatar, A. A., & Poulikakos, P. I. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4281 · Cited by 1,163
Synthetic Organic Electrochemistry: An Enabling and Innately Sustainable Method
Horn, E. J., Rosen, B. R., & Baran, P. S. (2016) · ACS Central Science · doi:10.1021/acscentsci.6b00091 · Cited by 1,068
The use of spirocyclic scaffolds in drug discovery
Zheng, Y., Tice, C. M., & Singh, S. B. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.06.081 · Cited by 1,036
Navigating chemical space for biology and medicine
Lipinski, C., & Hopkins, A. (2004) · Nature · doi:10.1038/nature03193 · Cited by 1,002
CGRP as the target of new migraine therapies — successful translation from bench to clinic
Edvinsson, L., Haanes, K. A., Warfvinge, K., & Krause, D. N. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0003-1 · Cited by 999
Ritchie, T. J., & Macdonald, S. J. F. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.07.014 · Cited by 901
Goadsby, P. J., Edvinsson, L., & Ekman, R. (1988) · Annals of Neurology · doi:10.1002/ana.410230214 · Cited by 863
Liu, Y., Han, S.-J., Liu, W.-B., & Stoltz, B. M. (2015) · Accounts of Chemical Research · doi:10.1021/ar5004658 · Cited by 825
Loibl, S., O'Shaughnessy, J., Untch, M., Sikov, W. M., Rugo, H. S., McKee, M. D., Huober, J., Golshan, M., von Minckwitz, G., Maag, D., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30111-6 · Cited by 768
Morris, E. J., Jha, S., Restaino, C. R., Dayananth, P., Zhu, H., Cooper, A., Carr, D., Deng, Y., Jin, W., Black, S., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0070 · Cited by 676
Ishikawa, M., & Hashimoto, Y. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101356p · Cited by 619
Targeting the PI3K–AKT–mTOR pathway: progress, pitfalls, and promises
Yap, T. A., Garrett, M. D., Walton, M. I., Raynaud, F., de Bono, J. S., & Workman, P. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.08.004 · Cited by 543
Adaptive immunity in HBV infection
Bertoletti, A., & Ferrari, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.026 · Cited by 483
Stepan, A. F., Subramanyam, C., Efremov, I. V., Dutra, J. K., O’Sullivan, T. J., DiRico, K. J., McDonald, W. S., Won, A., Dorff, P. H., Nolan, C. E., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300094u · Cited by 468
Ritchie, T. J., Macdonald, S. J. F., Young, R. J., & Pickett, S. D. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2010.11.014 · Cited by 442
Inhibition of cancer growth by resveratrol is related to its low bioavailability
Asensi, M., Medina, I., Ortega, A., Carretero, J., Baño, M. C., Obrador, E., & Estrela, J. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00911-5 · Cited by 388
Two‐ and Three‐dimensional Rings in Drugs
Aldeghi, M., Malhotra, S., Selwood, D. L., & Chan, A. W. E. (2014) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12260 · Cited by 372
Molecular obesity, potency and other addictions in drug discovery
Hann, M. M. (2011) · MedChemComm · doi:10.1039/c1md00017a · Cited by 363
Clemons, P. A., Bodycombe, N. E., Carrinski, H. A., Wilson, J. A., Shamji, A. F., Wagner, B. K., Koehler, A. N., & Schreiber, S. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012741107 · Cited by 346
Structural basis for RNA replication by the hepatitis C virus polymerase
Appleby, T. C., Perry, J. K., Murakami, E., Barauskas, O., Feng, J., Cho, A., Fox, D., Wetmore, D. R., McGrath, M. E., Ray, A. S., et al. (2015) · Science · doi:10.1126/science.1259210 · Cited by 339
Thorneloe, K. S., Cheung, M., Bao, W., Alsaid, H., Lenhard, S., Jian, M.-Y., Costell, M., Maniscalco-Hauk, K., Krawiec, J. A., Olzinski, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004276 · Cited by 337
Wang, S., Sun, W., Zhao, Y., McEachern, D., Meaux, I., Barrière, C., Stuckey, J. A., Meagher, J. L., Bai, L., Liu, L., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0799 · Cited by 328
Patchett, A. A., Nargund, R. P., Tata, J. R., Chen, M. H., Barakat, K. J., Johnston, D. B., Cheng, K., Chan, W. W., Butler, B., & Hickey, G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.7001 · Cited by 327
Kirkpatrick, P., & Ellis, C. (2004) · Nature · doi:10.1038/432823a · Cited by 327
Young, R. J., Green, D. V. S., Luscombe, C. N., & Hill, A. P. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.06.001 · Cited by 311
Kim, J., Kim, H., & Park, S. B. (2014) · Journal of the American Chemical Society · doi:10.1021/ja508343a · Cited by 308
The utilization of spirocyclic scaffolds in novel drug discovery
Zheng, Y.-J., & Tice, C. M. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1195367 · Cited by 299
Schreiber, S. L. (2009) · Nature · doi:10.1038/457153a · Cited by 292
Structural characterization of the human respiratory syncytial virus fusion protein core
Zhao, X., Singh, M., Malashkevich, V. N., & Kim, P. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.260499197 · Cited by 291
Zhao, Y., Yu, S., Sun, W., Liu, L., Lu, J., McEachern, D., Shargary, S., Bernard, D., Li, X., Zhao, T., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4005708 · Cited by 290
Conformational Restriction: An Effective Tactic in ‘Follow-On’-Based Drug Discovery
Fang, Z., Song, Y., Zhan, P., Zhang, Q., & Liu, X. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.50 · Cited by 268
Penning, T. D., Zhu, G.-D., Gandhi, V. B., Gong, J., Liu, X., Shi, Y., Klinghofer, V., Johnson, E. F., Donawho, C. K., Frost, D. J., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801171j · Cited by 268
Route to three-dimensional fragments using diversity-oriented synthesis
Hung, A. W., Ramek, A., Wang, Y., Kaya, T., Wilson, J. A., Clemons, P. A., & Young, D. W. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015271108 · Cited by 268
Locke, G. M., Bernhard, S. S. R., & Senge, M. O. (2019) · Chemistry – A European Journal · doi:10.1002/chem.201804225 · Cited by 261
Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity
Hill, A. P., & Young, R. J. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.05.016 · Cited by 258
Investigation of a Bicyclo[1.1.1]pentane as a Phenyl Replacement within an LpPLA 2 Inhibitor
Measom, N. D., Down, K. D., Hirst, D. J., Jamieson, C., Manas, E. S., Patel, V. K., & Somers, D. O. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00281 · Cited by 253
Pharmaceuticals that contain polycyclic hydrocarbon scaffolds
Stockdale, T. P., & Williams, C. M. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00477a · Cited by 250
Propellanes—From a Chemical Curiosity to “Explosive” Materials and Natural Products
Dilmaç, A. M., Spuling, E., de Meijere, A., & Bräse, S. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201603951 · Cited by 235
Urzhumtsev, A., Tête-Favier, F., Mitschler, A., Barbanton, J., Barth, P., Urzhumtseva, L., Biellmann, J.-F., Podjarny, A., & Moras, D. (1997) · Structure · doi:10.1016/s0969-2126(97)00216-5 · Cited by 233
Cordier, C., Morton, D., Murrison, S., Nelson, A., & O'Leary-Steele, C. (2008) · Natural Product Reports · doi:10.1039/b706296f · Cited by 215
C-Terminal octapeptide of cholecystokinin decreases food intake in obese men
Pi-Sunyer, X., Kissileff, H. R., Thornton, J., & Smith, G. P. (1982) · Physiology & Behavior · doi:10.1016/0031-9384(82)90230-x · Cited by 209
Pellicciari, R., Raimondo, M., Marinozzi, M., Natalini, B., Costantino, G., & Thomsen, C. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960254o · Cited by 202
Ohtake, Y., Sato, T., Kobayashi, T., Nishimoto, M., Taka, N., Takano, K., Yamamoto, K., Ohmori, M., Yamaguchi, M., Takami, K., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300884k · Cited by 174
p53 Activation by Small Molecules: Application in Oncology
Vassilev, L. T. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058174k · Cited by 174
Komatsu, S., Imoto, I., Tsuda, H., Kozaki, K.-I., Muramatsu, T., Shimada, Y., Aiko, S., Yoshizumi, Y., Ichikawa, D., Otsuji, E., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp116 · Cited by 173
Molecular complexity and fragment-based drug discovery: ten years on
Leach, A. R., & Hann, M. M. (2011) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2011.05.008 · Cited by 169
Prediction of Aqueous Solubility of Organic Compounds Based on a 3D Structure Representation
Yan, A., & Gasteiger, J. (2002) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci025590u · Cited by 162
Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-XL Inhibitor
Wang, L., Doherty, G. A., Judd, A. S., Tao, Z., Hansen, T. M., Frey, R. R., Song, X., Bruncko, M., Kunzer, A. R., Wang, X., et al. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00568 · Cited by 161
Fragment-based hit identification: thinking in 3D
Morley, A. D., Pugliese, A., Birchall, K., Bower, J., Brennan, P., Brown, N., Chapman, T., Drysdale, M., Gilbert, I. H., Hoelder, S., et al. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.07.011 · Cited by 160
Singh, N. P., Guha, R., Giulianotti, M. A., Pinilla, C., Houghten, R. A., & Medina‐Franco, J. L. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci800426u · Cited by 156
Charting Biologically Relevant Spirocyclic Compound Space
Müller, G., Berkenbosch, T., Benningshof, J. C. J., Stumpfe, D., & Bajorath, J. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201604714 · Cited by 156
3D Molecular Descriptors Important for Clinical Success
Kombo, D. C., Tallapragada, K., Jain, R., Chewning, J., Mazurov, A. A., Speake, J. D., Hauser, T. A., & Toler, S. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300445e · Cited by 139
Yang, Y., Engkvist, O., Llinàs, A., & Chen, H. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201548z · Cited by 139
Electrolytic Macrocyclizations: Scalable Synthesis of a Diazonamide‐Based Drug Development Candidate
Ding, H., DeRoy, P., Perreault, C., Larivée, A., Siddiqui, A., Caldwell, C. G., Harran, S., & Harran, P. G. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201411663 · Cited by 138
Modulating inflammation through the negative regulation of NF-κB signaling
Rothschild, D. E., McDaniel, D. K., Ringel-Scaia, V. M., & Allen, I. C. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir0817-346rrr · Cited by 129
Discovery of a Small Molecule MDM2 Inhibitor (AMG 232) for Treating Cancer
Rew, Y., & Sun, D. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500627s · Cited by 125
Molecular Characteristics for Solid-State Limited Solubility
Wassvik, C. M., Holmén, A. G., Draheim, R., Artursson, P., & Bergström, C. A. S. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701587d · Cited by 125
Goh, Y. L., Cui, Y. T., Pendharkar, V. V., & Adsool, V. A. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00018 · Cited by 124
Physicochemical Descriptors of Aromatic Character and Their Use in Drug Discovery
Ritchie, T. J., & Macdonald, S. J. F. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500515d · Cited by 120
The rise, fall and reinvention of combinatorial chemistry
Kodadek, T. J. (2011) · Chemical Communications · doi:10.1039/c1cc12102b · Cited by 116
Sampson, P. B., Liu, Y., Patel, N. K., Fehér, M., Forrest, B., Li, S.-W., Edwards, L. G., Laufer, R. S., Lang, Y., Ban, F., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500537u · Cited by 116
The thermodynamic basis for the use of lipophilic efficiency (LipE) in enthalpic optimizations
Shultz, M. D. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.08.030 · Cited by 105
Clemons, P. A., Wilson, J. A., Dančík, V., Muller, S., Carrinski, H. A., Wagner, B. K., Koehler, A. N., & Schreiber, S. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015024108 · Cited by 104
Beisner, D. R., Langerak, P., Parker, A. E., Dahlberg, C. M., Otero, F. J., Sutton, S., Poirot, L., Barnes, W., Young, M. A., Niessen, S., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20121072 · Cited by 92
Blocking the CGRP Pathway for Acute and Preventive Treatment of Migraine: The Evolution of Success
Dubowchik, G. M., Conway, C. M., & Xin, A. W. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01810 · Cited by 88
Lamanna, C., Bellini, M., Padova, A., Westerberg, G., & Maccari, L. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701407x · Cited by 86
Yuan, J.-Q., Tsoi, K. K. F., Yang, M. G., Wang, J. Y., Threapleton, D. E., Yang, Z., Zou, B., Mao, C., Tang, J. L., & Chan, F. K. L. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13642 · Cited by 86
Cox, B., Zdorichenko, V., Cox, P. B., Booker‐Milburn, K. I., Paumier, R., Elliott, L. D., Robertson-Ralph, M., & Bloomfield, G. C. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00039 · Cited by 85
Mackman, R. L., Mish, M., Chin, G., Perry, J. K., Appleby, T. C., Aktoudianakis, V., Metobo, S. E., Pyun, P., Niu, C., Daffis, S., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00100 · Cited by 84
Mackman, R. L., Steadman, V. A., Dean, D. K., Jansa, P., Poullennec, K. G., Appleby, T. C., Austin, C., Blakemore, C. A., Cai, R. Z., Cannizzaro, C. E., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00802 · Cited by 79
Michaelides, M. R., Kluge, A. F., Patane, M. A., Drie, J. H. V., Wang, C., Hansen, T. M., Risi, R. M., Mantei, R. A., Hertel, C., Karukurichi, K. R., et al. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00395 · Cited by 77
Shimada, J., Suzuki, F., Nonaka, H., & Ishii, A. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00083a018 · Cited by 72
Pishvaian, M. J., Slack, R. S., Jiang, W., He, A. R., Hwang, J. J., Hankin, A., Dorsch‐Vogel, K., Kukadiya, D., Weiner, L. M., Marshall, J. L., et al. (2018) · Cancer · doi:10.1002/cncr.31309 · Cited by 69
Brooks, C. A., Barton, L. S., Behm, D. J., Eidam, H. S., Fox, R. M., Hammond, M., Hoang, T. H., Holt, D. A., Hilfiker, M. A., Lawhorn, B. G., et al. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00274 · Cited by 65
Potent adenosine receptor antagonists that are selective for the A1 receptor subtype.
Martinson, E. A., Johnson, R., & Wells, J. N. (1987) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10428-8 · Cited by 62
Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules
Luker, T. J., Alcaraz, L., Chohan, K. K., Blomberg, N., Brown, D. S., Butlin, R. J., Elebring, T., Griffin, A. M., Guile, S. D., St-Gallay, S. A., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.07.074 · Cited by 60
Gorbunova, V. A., Beck, J. T., Hofheinz, R., Alfonso, P. G., Nechaeva, M., Gracián, A. C., Mangel, L., Élez, E., Deming, D. A., Ramanathan, R. K., et al. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0343-z · Cited by 57
Discovery of Novel Spiroindoline Derivatives as Selective Tankyrase Inhibitors
Shirai, F., Tsumura, T., Yashiroda, Y., Yuki, H., Niwa, H., Sato, S., Chikada, T., Koda, Y., Washizuka, K., Yoshimoto, N., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01888 · Cited by 57
MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology
Boga, S. B., Deng, Y., Zhu, L. W., Yang, N., Cooper, A. B., Shipps, G. W., Doll, R. J., Shih, N., Zhu, H. Y. H., Sun, R., et al. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00220 · Cited by 54
Pinkerton, A. B., Peddibhotla, S., Yamamoto, F., Slosky, L. M., Bai, Y., Maloney, P., Hershberger, P., Hedrick, M. P., Falter, B., Ardecky, R., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00340 · Cited by 54
Inhibition of Human Peptide Deformylase Disrupts Mitochondrial Function
Escobar-Alvarez, S., Gardner, J. R., Sheth, A., Manfredi, G., Yang, G., Ouerfelli, O., Heaney, M. L., & Scheinberg, D. A. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00469-10 · Cited by 53
Burks, H. E., Abrams, T. J., Kirby, C. A., Baird, J., Fekete, A., Hamann, L. G., Kim, S., Lombardo, F., Loo, A. T., Lubicka, D., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01468 · Cited by 52
Scaffold Flatness: Reversing the Trend
Tajabadi, F. M., Campitelli, M. R., & Quinn, R. J. (2013) · Springer Science Reviews · doi:10.1007/s40362-013-0014-7 · Cited by 51
Pilot-Scale Continuous Production of LY2886721: Amide Formation and Reactive Crystallization
Polster, C. S., Cole, K. P., Burcham, C. L., Campbell, B. M., Frederick, A. L., Hansen, M. M., Harding, M., Heller, M. R., Miller, M. T., Phillips, J. L., et al. (2014) · Organic Process Research & Development · doi:10.1021/op500204z · Cited by 51
The State of the Art of Chemical Biology
Altmann, K., Büchner, J., Kessler, H., Diederich, F., Kräutler, B., Lippard, S. J., Liskamp, R. M. J., Müller, K., Nolan, E. M., Samorı̀, B., et al. (2008) · ChemBioChem · doi:10.1002/cbic.200800758 · Cited by 49
Mould, D. P., Alli, C., Bremberg, U., Cartic, S., Jordan, A. M., Geitmann, M., Maiqués-Díaz, A., McGonagle, A. E., Somervaille, T. C. P., Spencer, G. J., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00462 · Cited by 48
Fujimoto, K., Matsuoka, E., Asada, N., Tadano, G., Yamamoto, T., Nakahara, K., Fuchino, K., Ito, H., Kanegawa, N., Moechars, D., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00309 · Cited by 47
Scott, J. S., Bailey, A., Davies, R. D. M., Degorce, S. L., MacFaul, P. A., Gingell, H., Moss, T., Norman, R. A., Pink, J. H., Rabow, A. A., et al. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00413 · Cited by 43
Nußbaumer, P., Dorfstaetter, G., Grassberger, M. A., Leitner, I., Meingassner, J. G., Thirring, K., & Stuetz, A. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00067a010 · Cited by 40
Appleman, L. J., Beumer, J. H., Jiang, Y., Lin, Y., Ding, F., Puhalla, S., Swartz, L. K., Owonikoko, T. K., Harvey, R. D., Stoller, R. G., et al. (2019) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-019-03960-w · Cited by 40
Li, Y., Zhao, J., Gutgesell, L. M., Shen, Z., Ratia, K. M., Dye, K., Dubrovskyi, O., Zhao, H., Huang, F., Tonetti, D. A., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00456 · Cited by 40
Shirai, F., Mizutani, A., Yashiroda, Y., Tsumura, T., Kano, Y., Muramatsu, Y., Chikada, T., Yuki, H., Niwa, H., Sato, S., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00045 · Cited by 38
Overexpression of peptide deformylase in breast, colon, and lung cancers
Randhawa, H., Chikara, S., Gehring, D., Yıldırım, T., Menon, J., & Reindl, K. M. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-321 · Cited by 37
Pettus, L. H., Bourbeau, M. P., Bradley, J., Bartberger, M. D., Chen, K., Hickman, D., Johnson, M., Liu, Q., Manning, J. R., Nañez, A., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01034 · Cited by 37
Kong, D., Xue, T., Guo, B., Cheng, J., Liu, S., Wei, J., Lu, Z., Liu, H., Gong, G., Lan, T., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01971 · Cited by 36
Zhang, C., Li, F., Yan, Y. Q., Huang, A., He, P., Lei, M., Wang, J., Huang, L., Liu, Z., Liu, J., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00253 · Cited by 34
Discovery of AZD3147: A Potent, Selective Dual Inhibitor of mTORC1 and mTORC2
Pike, K. G., Morris, J. J., Ruston, L., Pass, S. L., Greenwood, R. D. R., Williams, E. J., Demeritt, J., Culshaw, J. D., Gill, K., Pass, M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501778s · Cited by 31
Sherwood, A. M., Crowley, R. S., Paton, K. F., Biggerstaff, A., Neuenswander, B., Day, V. W., Kivell, B. M., & Prisinzano, T. E. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00148 · Cited by 31
Velcicky, J., Bodendorf, U., Rigollier, P., Epple, R., Beisner, D. R., Guerini, D., Smith, P., Liu, B., Feifel, R., Wipfli, P., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01371 · Cited by 30
Sorbinil, an Aldose Reductase Inhibitor, in Fighting Against Diabetic Complications
Huang, Q., Liu, Q., & Ouyang, D. (2018) · Medicinal Chemistry · doi:10.2174/1573406414666180524082445 · Cited by 30
Tian, J. Y., Huang, K., Krishnan, S., Svabek, C., Rowe, D. C., Brewah, Y. A., Sanjuán, M. A. F., Patera, A. C., Kolbeck, R., Herbst, R., et al. (2013) · Journal of General Virology · doi:10.1099/vir.0.049254-0 · Cited by 29
Discovery of a GPR40 Superagonist: The Impact of Aryl Propionic Acid α-Fluorination
Huang, H., Meegalla, S. K., Lanter, J. C., Winters, M. P., Zhao, S., Littrell, J. B., Qi, J., Rady, B., Lee, P. S., Liu, J., et al. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00444 · Cited by 28
Mateu, N., Kidd, S. L., Kalash, L. N., Sore, H. F., Madin, A., Bender, A., & Spring, D. R. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201803143 · Cited by 27
Hobbs, H., Bravi, G., Campbell, I. B., Convery, M. A., Davies, H., Inglis, G. G. A., Pal, S., Peace, S., Redmond, J. M., & Summers, D. M. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00348 · Cited by 26
af Rosenschöld, M. M., Johannesson, P., Nikitidis, A., Tyrchan, C., Chang, H., Rönn, R., Chapman, D., Ullah, V., Nikitidis, G., Glader, P., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00555 · Cited by 26
Jonckers, T. H. M., Tahri, A., Vijgen, L., Berke, J. M., Lachau‐Durand, S., Stoops, B., Snoeys, J., Leclercq, L., Tambuyzer, L., Lin, T., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00382 · Cited by 25
Thomas, A. A., Hunt, K. W., Newhouse, B., Watts, R. J., Liu, X., Vigers, G. P. A., Smith, D. J., Rhodes, S. P., Brown, K. D., Otten, J. N., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5015132 · Cited by 24
Design and Synthesis of Styrenylcyclopropylamine LSD1 Inhibitors
Gehling, V. S., McGrath, J. P., Duplessis, M., Khanna, A., Brucelle, F., Vaswani, R. G., Côté, A., Stuckey, J. I., Watson, V. G., Cummings, R. T., et al. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00060 · Cited by 23
Takayama, K., Mori, K., Tanaka, A., Nomura, E., Sohma, Y., Mori, M., Taguchi, A., Taniguchi, A., Sakane, T., Yamamoto, A., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00694 · Cited by 20
La, D. S., Salituro, F. G., Botella, G. M., Griffin, A. M., Bai, Z., Ackley, M. A., Dai, J., Doherty, J., Harrison, B. L., Hoffmann, E. C., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00591 · Cited by 20
Taylor, A. P., Swewczyk, M., Kennedy, S., Trush, V. V., Wu, H., Zeng, H., Dong, A., de Freitas, R. F., Tatlock, J. H., Kumpf, R. A., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00112 · Cited by 19
Scott, J. S., Breed, J., Carbajo, R. J., Davey, P. R. J., Greenwood, R. D. R., Huynh, H. K., Klinowska, T. C. M., Morrow, C. J., Moss, T. A., Polański, R., et al. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00370 · Cited by 16
Cheung, M., Tangirala, R. S., Bethi, S. R., Joshi, H. V., Ariazi, J. L., Tirunagaru, V. G., & Kumar, S. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00450 · Cited by 13
Discovery of Orally Efficacious Tetrahydrobenzimidazoles as TGR5 Agonists for Type 2 Diabetes
Zhang, X., Wall, M., Sui, Z., Kauffman, J. A., Hou, C., Chen, C., Du, F., Kirchner, T., Liang, Y. T., Johnson, D. L., et al. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00116 · Cited by 11
Oxytocin antagonists: the next frontier in PE treatment
Gül, M., & Şerefoğlu, E. C. (2019) · Nature Reviews Urology · doi:10.1038/s41585-019-0238-7 · Cited by 11
Kerns, J. K., Busch‐Petersen, J., Fu, W., Boehm, J. C., Nie, H., Muratore, M., Bullion, A. M., Lin, G., Li, H., Davis, R., et al. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00291 · Cited by 9
The art and practice of structure-based drug design: A molecular modeling perspective
(1996) · doi:10.1002/(sici)1098-1128(199601)16:1<3::aid-med1>3.0.co;2-6
Cited by
Spirocyclic Scaffolds in Medicinal Chemistry
Hiesinger, K., Dar’in, D., Proschak, E., & Krasavin, M. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01473 · Cited by 618
Photocatalysis in the Life Science Industry
Candish, L., Collins, K. D., Cook, G. C., Douglas, J. J., Gómez-Suárez, A., Jolit, A., & Keess, S. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00416 · Cited by 428
Metadata
- Authors
- Talele, T. T.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-08-17
- Volume
- 63
- Issue
- 22
- Pages
- 13291-13315
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W3063814160
- Cited by
- 424
- References
- 124
- FWCI
- 19.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.